Rohit Anthony Sinha
Overview
Explore the profile of Rohit Anthony Sinha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1959
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chakravarti B, Rajput S, Srivastava A, Sharma L, Sinha R, Chattopadhyay N, et al.
Phytother Res
. 2024 Oct;
38(12):6062-6081.
PMID: 39480044
Female hormone-dependent cancers depend on estrogen for their growth. Numerous studies have explored the antitumor effect of dietary isoflavones on female hormone-dependent cancers. Still, few clinical evidence supports the use...
2.
Singh J, Hussain Y, Meena A, Sinha R, Luqman S
FEBS Lett
. 2024 Oct;
598(24):3036-3052.
PMID: 39394402
Non-small cell lung cancer comprises up to 85% of lung cancer cases and has a poor prognosis. At present, there are still no effective treatments for this illness. Evidence suggests...
3.
Raza S, Siddiqui J, Srivastava A, Chattopadhyay N, Sinha R, Chakravarti B
Autophagy Rep
. 2024 Jul;
3(1).
PMID: 39006309
Breast cancer is a heterogeneous disease, with a subpopulation of tumor cells known as breast cancer stem cells (BCSCs) with self-renewal and differentiation abilities that play a critical role in...
4.
Saxena P, Srivastava J, Rai B, Tripathy N, Raza S, Sinha R, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jan;
1870(3):167025.
PMID: 38237741
Background: Bone marrow mesenchymal stem cells (BM-MSC) are an integral part of the BM niche that is essential to maintain hematopoietic homeostasis. In aplastic anemia (AA), a few studies have...
5.
Hussain Y, Singh J, Meena A, Sinha R, Luqman S
Environ Toxicol
. 2023 Oct;
39(2):840-856.
PMID: 37853854
Introduction: Hepatocellular carcinoma (HCC) is a common solid cancer and the leading cause of cancer deaths worldwide. Sorafenib is the first drug used to treat HCC but its effectiveness needs...
6.
Raza S, Shahi A, Medhe P, Tewari A, Gupta P, Rajak S, et al.
Biochim Biophys Acta Mol Cell Res
. 2023 Sep;
1871(1):119597.
PMID: 37741573
Dietary fructose intake through increased consumption of refined sugar induces hepatic de novo lipogenesis (DNL), a major contributor to hepatic steatosis in NAFLD, however, it's mechanism is not completely understood....
7.
Hussain Y, Meena A, Sinha R
Toxicol In Vitro
. 2023 Aug;
93:105666.
PMID: 37611852
Combination therapy has been proposed as a promising approach for lung cancer treatment, as it can enhance anticancer efficacy, and reduce dosages and adverse effects. This study aimed to explore...
8.
Singh J, Hussain Y, Meena A, Luqman S, Sinha R
Int J Biol Macromol
. 2023 Aug;
252:126328.
PMID: 37579900
Lung cancer is the most common and lethal cancer worldwide, yet there are no adequate and novel medications to control this illness. Previous reports suggested the potential of protein kinases...
9.
Hussain Y, Singh J, Meena A, Sinha R, Luqman S
Phytother Res
. 2023 Jul;
37(10):4819-4837.
PMID: 37468281
Combining anti-cancer drugs has been exploited as promising treatment strategy to target lung cancer. Synergistic chemotherapies increase anti-cancer effect and reduce effective drug doses and side effects. In this study,...
10.
Chakravarti B, Siddiqui J, Sinha R, Raza S
Biochem Pharmacol
. 2023 Apr;
212:115550.
PMID: 37060962
Cancer stem cells (CSCs) are a subset of cancer cells with self-renewal ability and tumor initiating properties. Unlike the other non-stem cancer cells, CSCs resist traditional therapy and remain a...